Quantification of oteseconazole in rat plasma using LC-MS/MS and its application to pharmacokinetic study
DOI:
https://doi.org/10.69857/joapr.v12i4.485Keywords:
Oteseconazole, posaconazole, Bioanalytical methods, rat plasma, PharmacokineticsAbstract
Background: Oteseconazole is a new molecule launched for human treatment. However, the information is not available in the public domain for analyzing blood samples. This study describes the method development and validation using LC-MS/MS to measure the concentration of Oteseconazole in rat plasma. Methodology: The analysis method was developed using a phenyl column, which was utilized to accomplish separation. Furthermore, the mobile phase was a combination of acetonitrile and 0.1% formic acid in water, with a ratio of 30:70 (v/v). The sample was introduced into the system at a 1.0 mL/min flow rate, and the injection volume was 10 μLand analyzed for five minutes using mass spectrometer +ESI mode. Results and discussion: MRM is used to quantify Oteseconazole and Posaconazole by analyzing the transitions of their respective m/z values. The concentration ranges of Oteseconazole were 5-100 ng/mL. The correlation coefficient of Oteseconazole was found to be 0. 999. HQC, MQC, LQC, and LLQC precision and accuracy were determined to be 98.60%, 98.69%, 96.11%, and 94.48%, respectively. Respectively, the accuracy recovery of Oteseconazole was determined to be 97.48%. In pharmacokinetic studies, it was observed that Oteseconazole exhibited an average AUC0-t value of 1386 ng-hr/ml and a Cmax value of 44.864 ng/ml in rats. Conclusion: The validated approach has effectively demonstrated the determination of pharmacokinetic parameters after the oral administration of Oteseconazole in Wister rats.
Downloads
References
Rudrapal M, Kothawade A, Ezzat S, Egbuna C. Bioanalysis: methods, techniques, and applications. Analytical Techniques in Biosciences, Academic Press, 1, 1-24 (2022).
Shi J, Chen X, Diao J, Jiang L, Li L, Li S, Liang W, Jin X, Wang Y, Wong C, Zhang XT, Tse FLS. Bioanalysis in the Age of New Drug Modalities, American Association of Pharmaceutical Scientists Journal, 64, 1-15 (2021).
Moein M, Beqqali A, Abdel-Rehim M. Bioanalytical method development and validation: Critical concepts and strategies. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1043, 3-11 (2017).
Tripathi A, Sathua K, Pachauri V, Flora S. Collection, storage, and transportation of samples for offsite analysis, Academic Press, 7, 133-149 (2020).
Armenta S, Farncesc A, Garrigues S, Guardia M. Smart materials for sample preparation in bioanalysis: A green overview. Sustainable Chemistry and Pharmacy, 21, 100411(2021).
Ingle RG, Zeng S, Jiang H, Fang WJ. Current developments of bioanalytical sample preparation techniques in pharmaceuticals. Journal of Pharmaceutical Analysis, 12, 517-529 (2022).
Nikam S, Jagdale A, Boraste S, Patil S. Bioanalysis - Method Development, Validation, Sample Preparation, its Detection Techniques and its Application. Asian Journal of Pharmaceutical Analysis, 11(4), 297-305 (2021).
Reddy K, Gandla K, Babu P, Chakravarthy M, Chandrasekhar P, Sagapola R. A Critical Review on Bioanalytical Method Development and Validation of Few Oncology Drugs by Using LC-MS-MS. Journal of Pharmaceutical Negative Results, 13(1), 16–27 (2022).
Reddy K, Haque M. Bioanalytical method development and validation of Atrasentan in human plasma using verapamil as internal standard by liquid chromatography coupled with tandem mass spectrometry. International Journal of Health Sciences, 6, 625–638 (2022).
Reddy K, Haque M. Development and Validation of a High Throughput LC-MS/MS Method for Quantitation of Ipilimumab in Human Plasma. International Journal of Pharmaceutical Quality Assurance, 13, 303-307 (2022).
Nimmakayala M, Kolli D, Bhavani D. Bioanalytical method development and validation of maralixibat in rat plasma by LC-MS/MS detection and its application to a pharmacokinetic study. International journal of applied pharmaceutics, 15, 166–172(2023).
De S. Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal Candidiasis. Current Medicinal Chemistry, 30, 4170-4175 (2023).
Sobel J, Nyirjesy P. Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis. Future Microbiology. 16, 1453–1461 (2021).
Hoy S. Oteseconazole: First Approval. Drugs, 82, 1017–1023 (2022).
Martens M, Maximos B, Degenhardt T, Person K, Curelop S, Ghannoum M, Flynt A, Brand S. Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections. Gynecology, 227, 880 (2022).
Fung S, Shirley M. Oteseconazole in recurrent vulvovaginal candidiasis: a profile of its use. Drugs & Therapy Perspectives, 39, 263–269 (2023).
Melam N, Karavadi T, Saibabu C. Method Development and Validation for the Determination of Related Compounds in Posaconazole by RP-HPLC. International Journal of Research Publication and Reviews, 4, 2849-2861 (2023).
Mahaparale S. Yadav A. Bioanalytical Method Development and Validation of Posacanazole by RP-HPLC Method. International Journal of Creative Research Thoughts, 8, 1-11 (2020).
Namburi L, Amara B, Kalyani K, Babji P, Koduri S, Koya P. Bioanalytical LC-MS/MS method for determination and comparison of selexipag assay in various biological materials and its application to pharmacokinetics studies in rat plasma. International Journal of Research in Pharmaceutical Sciences, 11, 2210-20 (2020).
Alumuri T, Merugu K, Amarababu NLA, Kurnool A. Peramivir and related impurities in rat plasma and its applications in pharmacokinetic studies (bioanalytical method development and validation by LC-MS/MS). International Journal of Applied Pharmaceutics, 14, 53-61 (2022).
Bhosale A. Importance of bioanalysis in drug discovery and development: A review. International Journal of Pharmaceutical Science and Research, 5, 55-58 (2020).
Gholve R, Pekamwar S, Wadher S. Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form. Future Journal of Pharmaceutical Sciences, 7, 224 (2021).
Pal V, Pal Y. Analytical method development and method validation for determination assay and content uniformity of levonorgestrel by reversed-phase high-performance liquid chromatography. Asian Journal of pharmaceutical and clinical research, 13, 101-107 (2020).
Sveshnikova N, Yuan T, Warren J. Development and validation of a reliable LC–MS/MS method for quantitative analysis of usnic acid in Cladonia uncialis. BMC Research Notes, 12, 550 (2019).
Rao K, babu N, Koganti K, Palakeeti B, Srinivas K. Related substances method development and validation of an LCMS/MS method for quantification of selexipag and its related impurities in rat plasma and its application to pharmacokinetic studies. SN Applied Sciences, 3, 1-12 (2021).
Fazli A, Panigrahy B, Kumar V. Multiple-reaction monitoring (MRM) LC–MS/MS quantitation of venlafaxine and its O-desmethyl metabolite for a preclinical pharmacokinetic study in rabbits. Scientific Reports, 12, 9322 (2022).
Yunlin F, Wenkui L, Franck P. Non-regulated LC–MS/MS bioanalysis in support of early drug development: a Novartis perspective. Bioanalysis, 15, 204 (2020).
Thakur A, Tan Z, Kameyama T et al. Bioanalytical strategies in drug discovery and development. Drug Metabolism Review, 53(3), 434–458 (2021).
Guifeng J, Terry Z, Kayvon J. Quantitative Analysis of Drug Analytes in Rat and Human Plasma using LC/MS with Online Sample Preparation, Thermo Fisher Scientific. https://assets.thermofisher.cn/TFS-Assets/CMD/posters/PO-Quantitative-Analysis-Drug-Analytes-Rat-Human-Plasma-EN.pdf cited on 01 January 2024.
Hegde R, Padya S, Soman, S. A simple, precise, and sensitive HPLC method for quantification of letrozole in rat plasma: development, validation, and preclinical pharmacokinetics. Journal of Analytical Science and Technology,12, 25 (2021).
US Food and Drug Administration Center for Biologics Evaluation and Research, M10 Bioanalytical method validation and study sample analysis Guidance for Industry, (2022). https://www.fda.gov/media/162903/download cited on 01 January 2024.
US Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Center for Veterinary Medicine. Bioanalytical Method Validation Guidance for Industry. Biopharmaceutics, (2018).
https://www.fda.gov/media/70858/download cited on 01 January 2024.
Saudagar RB, Thete PG. Bioanalytical Method Validation: A Concise Review. Asian Journal of Research in Pharmaceutical Science, 8(2), 107-114 (2018).
Leuschner M, Cromarty D. Bioanalytical method optimization for simultaneous quantification of structurally related probe drugs in a phenotyping cocktail using liquid chromatography-tandem mass spectrometry. Separation Science Plus, 7(3), 1-12 (2024).
Abdessadek M, Kharbach M, Hayat B, Amraoui B, Khabbal Y. Validation steps and parameters of bioanalytical methods using in clinical studies: A narrative review. Journal of Applied Pharmaceutical Science, 13(08), 68-83 (2023).
Amruta S. Kadam, Nayana V. Pimpodkar, Puja S.Gaikwad, Sushila D. Chavan.. Bioanalytical Method Validation. Asian Journal of Pharmaceutical Analysis, 5(4), 219-225 (2015).
Paval P, Kanase K. Bioanalytical Method Development and Validation: A Review. International Journal of Pharmacy and Pharmaceutical Research, 27(1), 376-390 ( 2023).
Wright K, Bollen M, David J, Mepham B, Alcázar Magaña A, McClure C, Maier C, Quinn J, Soumyanath A. Bioanalytical method validation and application to a phase 1, double-blind, randomized pharmacokinetic trial of a standardized Centella asiatica (L.) Urban water extract product in healthy older adults. Front Pharmacology, 14, 1228030 (2023).
Sabale V, Jiwankar M, Sabale P. Bioanalytical method development, validation and quantification of flutamide in spiked rat plasma by using high-performance liquid chromatography. Future Journal of Pharmaceutical Sciences, 9(75), 1-7 (2023).
Le Q, Duong V, Lee S, Nguyen T, Maeng H. Bioanalytical method validation, biopharmaceutical and pharmacokinetic evaluation of GSK-650394, a serum- and glucocorticoid-regulated kinase 1 inhibitor. Arabian Journal of Chemistry, 16(2), 104462 (2023).
Hopfgartner G. Bioanalytical method validation: How much should we do and how should we document?. Analytical and Bioanalytical Chemistry, 412, 531–532(2020).
Bio Pharma. Bioanalytical method validation focus on sample stability. Bio Pharma Services Inc. (2022). Available online on:
https://www.biopharmaservices.com/blog/bioanalytical-method-validation-focus-on-sample-stability/ Cited on 22 Mar 2024.
Celegence. Stability Assessments as a Part of Bioanalytical Method Validation. Understanding stability in bioanalytical methods ensuring. Available online: https://www.celegence.com/bioanalytical-stability-assessments-method-validation/ Cited on 22 Mar 2024.
Gniazdowska E, Goch W, Giebułtowicz J, Rudzki PJ. Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach. Molecules, 27(2), 457 (2022).
Lowes S, Boterman M, Doig M, Breda M, Jersey J, LeLacheur R, Fang X. Recommendations on Bioanalytical Method Stability Implications of Co-Administered And Co-Formulated Drugs By Global Cro Council For Bioanalysis (Gcc). Bioanalysis, 4(17), 2117–2126 (2012).
Abd-Elaziz K, Cheng R, Chen J, Maarse H, Lee Y, Yang W, Chien B, Diamant Z, Kosterink J, Touw D. Validation of a method for the determination of Aderamastat (FP-025) in K2EDTA human plasma by LC-MS/MS. Journal of Chromatography B, 1245, 124244 (2024).
Sahithi A, Deepti A. Development and Validation of New LC-MS/MS Bioanalytical Method of Tremelimumab in Rat Plasma by Using Nivolumab as Internal Standard and Its Application with Pharmacokinetic Studies. International Journal of Drug Delivery Technology, 14(2), 727-731 (2024).
Yi X, Lan X. LC-MS/MS method for the determination of erianin in rat plasma: Application to a pharmacokinetic study. Biomedical Chromatography, 34, e4826 (2020).
Martin K, Kristyna S, Wim D, Ladislav V, Katerina H, Bronislav J, Tomas P. Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine (DCK) in Wistar rats. Toxicologie Analytique et Clinique, 34, S41-S42 (2022).
Antonowski T, Osowski A, Szczesny D, Szablińska-Piernik J, Juśkiewicz J, Lahuta L, Rynkiewicz A, Wojtkiewicz J. Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model. International Journal of Molecular Sciences, 23, 11246 (2022).
Manoj K, Dandapat S, Sinha M, Rajput B. Kumar A. Different blood collection methods from rats: A review. Balneo Research Journal, 8, 46-50 (2017).
IACUC Guideline. Blood Collection: The Rat. Office of research institutional animal care and use program, Effective April 2022. Available online: https://iacuc.ucsf.edu/sites/g/files/tkssra751/f/wysiwyg/GUIDELINE%20-%20Blood%20Collection%20-%20Rat.pdf cited on 01 Feb 2024.
Wang Y, Yu X, Chen C, Zhang X, Ye Z, Yang J, Chen Y, Xiang Z, Lin G, Zhou Z. Development of UPLC-MS/MS method for the determination of colistin in plasma and kidney and its application in pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis, 233, 115440 (2023).
Wu F, Zhou Y, Li L, Shen X, Chen G, Wang X, Liang X, Tan M, Huang Z. Computational Approaches in Preclinical Studies on Drug Discovery and Development. Frontiers in Chemistry, 11(8), 726 (2020).
Kantipudi R, Pavuluri S. Bioanalytical method development and validation for the simultaneous estimation of Olanzapine and Samidorphan in rabbit plasma by using HPLC–MS/MS and application to pharmacokinetic study. Future Journal Pharmaceutical Sciences, 10(1), 1-14 (2024).
Naveen VMK, Veeraswami B, Srinivasa Rao G. High Response Bio-Analytical Validation approach of Nadolol and Bendroflumethiazide by LC-MS/MS on Rat plasma. International Journal of Research in Pharmaceutical Sciences, 11(SPL4), 2272-2279 (2020).
Product Information Leaflet. VIVJOATM (oteseconazole) capsules, for oral use. The united state food and drug administration, (2022). Available online: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215888s000lbl.pdf. Cited on Assessed on 30 Mar 2024.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Krishna Phani Chandra Susararla, Om Shelke, Neetu Shorgar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.